Skip to main content
Dot gov

Official websites use the Texas HHS logo.
The Texas HHS logo means this is an official website of Texas Health and Human Services.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

5. References

  1. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2024. Available at: http://www.clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed June 11, 2024.
  2. Hydroxyurea (Droxia) package insert. E.R. Squibb & Sons, LLC. July 2021.
  3. Hydroxyurea (Siklos) package insert. Medunik. November 2023.
  4. L-glutamine (Endari) package insert. Emmaus Medical, Inc., October 2020.
  5. Voxelotor (Oxbryta) package insert. Global Blood Therapeutics Inc. August 2023.
  6. Crizanlizumab (Adakveo) package insert. Novartis Pharmaceuticals Corporation. September 2022.
  7. Exagamglogene (Casgevy) package insert. Vertex Pharmaceuticals Incorporated. January 2024.
  8. Lovotibeglogene (Lyfgenia) package insert. Bluebird Bio, Inc. December 2023.
  9. Niihara Y, Miller ST, Kanter J, et al. Investigators of the phase 3 trial of l-glutamine in sickle cell disease. A phase 3 trial of l-glutamine in sickle cell disease. N Engl J Med. 2018;379(3):226-235. [PubMed 30021096] 10.1056/NEJMoa1715971
  10. Vichinsky E, Hoppe CC, Ataga KI, et al. A phase 3 randomized trial of voxelotor in sickle cell disease. N Engl J Med. 2019;381:509-19. doi: 10.1056/NEJMoa1903212.